Skip Navigation


Nucleic Acids Research Advance Access originally published online on March 13, 2007
Nucleic Acids Research 2007 35(7):e52; doi:10.1093/nar/gkl1118
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (5035K) Freely available
Right arrow Screen PDF (707K) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
35/7/e52    most recent
gkl1118v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Beuvink, I.
Right arrow Articles by Weiler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beuvink, I.
Right arrow Articles by Weiler, J.
Related Collections
Right arrow Microarray
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2007, Vol. 35, No. 7 e52
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Methods Online

A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs

Iwan Beuvink1, Fabrice A. Kolb2, Wolfgang Budach3, Arlette Garnier1, Joerg Lange1, Francois Natt1, Uwe Dengler1, Jonathan Hall1, Witold Filipowicz2 and Jan Weiler1,*

1Novartis Institutes for BioMedical Research, Genome and Proteome Sciences, CH-4002 Basel, Switzerland, 2Friedrich Miescher Institute for Biomedical Research, PO Box 2543, CH-4002 Basel, Switzerland and 3Novartis Pharma AG, Biomarker Development, CH-4002 Basel, Switzerland

*To whom correspondence should be addressed. Tel: +49-61 3246142; Fax: +41-61-3242217; Email: jan.weiler{at}novartis.com Correspondence may also be addressed to Witold Filipowicz. Tel: +41-61 6974128; Fax: +41-61-6973976; E-mail: witold.filipowicz{at}fmi.ch

Received August 8, 2006. Revised October 30, 2006. Accepted February 27, 2007.

Microarrays to examine the global expression levels of microRNAs (miRNAs) in a systematic in-parallel manner have become important tools to help unravel the functions of miRNAs and to understand their roles in RNA-based regulation and their implications in human diseases. We have established a novel miRNA-specific microarray platform that enables the simultaneous expression analysis of both known and predicted miRNAs obtained from human or mouse origin. Chemically modified 2'-O-(2-methoxyethyl)-(MOE) oligoribonucleotide probes were arrayed onto Evanescent Resonance (ER) microchips by robotic spotting. Supplementing the complementary probes against miRNAs with carefully designed mismatch controls allowed for accurate sequence-specific determination of miRNA expression profiles obtained from a panel of mouse tissues. This revealed new expression signatures of known miRNAs as well as of novel miRNAs previously predicted using bioinformatic methods. Systematic confirmation of the array data with northern blotting and, in particular, real-time PCR suggests that the described microarray platform is a powerful tool to analyze miRNA expression patterns with rapid throughput and high fidelity.


The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.

Present address: Fabrice A. Kolb, Protease Platform, Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland Jonathan Hall, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Drummond, J. J. McCarthy, C. S. Fry, K. A. Esser, and B. B. Rasmussen
Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1333 - E1340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Hu, G. Ren, J.-L. Liu, Z.-A. Zhao, Y.-S. Yu, R.-W. Su, X.-H. Ma, H. Ni, W. Lei, and Z.-M. Yang
MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation
J. Biol. Chem., August 22, 2008; 283(34): 23473 - 23484.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Chen, J. Lozach, E. W. Garcia, B. Barnes, S. Luo, I. Mikoulitch, L. Zhou, G. Schroth, and J.-B. Fan
Highly sensitive and specific microRNA expression profiling using BeadArray technology
Nucleic Acids Res., August 1, 2008; 36(14): e87 - e87.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
J. Xu and C. Wong
A computational screen for mouse signaling pathways targeted by microRNA clusters
RNA, July 1, 2008; 14(7): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Jeyaseelan, K. Y. Lim, and A. Armugam
MicroRNA Expression in the Blood and Brain of Rats Subjected to Transient Focal Ischemia by Middle Cerebral Artery Occlusion
Stroke, March 1, 2008; 39(3): 959 - 966.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.